Human medicines

Typhim-Vi

Recall | Medicines | 25/09/2012

Sanofi Pasteur MSD GmbH has informed its supplied customers in a letter dated 24.09.2012 that a voluntary recall is being carried out for the…

Typhim-Vi Read more

Truvada

Recall | Medicines | 05/09/2012

The parallel distributor, HAEMATO PHARM AG; has informed its supplied customers by letter dated 5.9.2012 that the batches placed on the market by him…

Truvada Read more

Carmubris (Ben Venue)

Replacement | Medicines | 27/08/2012

The marketing authorization holder informed its supplied customers in a letter dated August 27, 2012, that in the course of stability tests at the…

Carmubris (Ben Venue) Read more

Thymoglobulin

Replacement | Medicines | 13/08/2012

The distribution partner sanofi-aventis GmbH Austria informed its supplied customers by letter dated August 13, 2012, that aggregates above the…

Thymoglobulin Read more

Directions for use Ropivacaine

Medicines | 08/08/2012

Misleading wording in package insert, see related file.

Directions for use Ropivacaine Read more

Package Leaflet Mitomycin

Medicines | 06/08/2012

Packaged finished product batches as of May 2011 contain incorrect information in the package insert, see associated file.

Package Leaflet Mitomycin Read more

Allergovit

Recall | Medicines | 13/07/2012

The marketing authorization holder informed its customers by letters dated July 10 and 13, 2012, that the patient-specific batches could have an…

Allergovit Read more

Effortil comp. drops

Recall | Medicines | 04/07/2012

The marketing authorization holder informed its supplied customers in a letter dated July 2, 2012, that quality deviations were detected in current…

Effortil comp. drops Read more

Propofol

Recall | Medicines | 29/06/2012

The marketing authorization holder informed its supplied customers by letter dated 28.06.2012 that the transport carton of batch A010816 is labeled…

Propofol Read more

Anapen (Epinephrin)

Safety warnings | Medicines | 05/06/2012
Recently, a quality defect was identified during further development of the product, according to which the epinephrine solution is not delivered or is delivered insufficiently in the event of an anaphylactic emergency.
Anapen (Epinephrin) Read more
Email

Further inquiry note